Zobrazeno 1 - 10
of 16
pro vyhledávání: '"de las Heras-Dueña L"'
Autor:
Penzo M; GSK Global Health, Severo Ochoa 2, Tres Cantos 28760 Madrid, Spain.; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, United Kingdom., de Las Heras-Dueña L; GSK Global Health, Severo Ochoa 2, Tres Cantos 28760 Madrid, Spain., Mata-Cantero L; GSK Global Health, Severo Ochoa 2, Tres Cantos 28760 Madrid, Spain., Diaz-Hernandez B; GSK Global Health, Severo Ochoa 2, Tres Cantos 28760 Madrid, Spain., Vazquez-Muñiz MJ; GSK Global Health, Severo Ochoa 2, Tres Cantos 28760 Madrid, Spain., Ghidelli-Disse S; Cellzome GmbH, a GlaxoSmithKline Company, Meyerhofstrasse 1, 69117, Heidelberg, Germany., Drewes G; Cellzome GmbH, a GlaxoSmithKline Company, Meyerhofstrasse 1, 69117, Heidelberg, Germany., Fernandez-Alvaro E; GSK Global Health, Severo Ochoa 2, Tres Cantos 28760 Madrid, Spain., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, United Kingdom. david.baker@lshtm.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2019 May 07; Vol. 9 (1), pp. 7005. Date of Electronic Publication: 2019 May 07.
Autor:
Keurulainen L; †Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5 E (P.O. Box 56), FI-00014 Helsinki, Finland., Vahermo M; †Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5 E (P.O. Box 56), FI-00014 Helsinki, Finland., Puente-Felipe M; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Sandoval-Izquierdo E; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Crespo-Fernández B; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Guijarro-López L; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Huertas-Valentín L; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., de las Heras-Dueña L; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Leino TO; †Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5 E (P.O. Box 56), FI-00014 Helsinki, Finland., Siiskonen A; †Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5 E (P.O. Box 56), FI-00014 Helsinki, Finland., Ballell-Pages L; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Sanz LM; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Castañeda-Casado P; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Jiménez-Díaz MB; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Martínez-Martínez MS; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Viera S; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Kiuru P; †Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5 E (P.O. Box 56), FI-00014 Helsinki, Finland., Calderón F; ‡Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain., Yli-Kauhaluoma J; †Faculty of Pharmacy, Division of Pharmaceutical Chemistry and Technology, University of Helsinki, Viikinkaari 5 E (P.O. Box 56), FI-00014 Helsinki, Finland.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2015 Jun 11; Vol. 58 (11), pp. 4573-80. Date of Electronic Publication: 2015 May 19.
Autor:
Armstrong, Jane F.1 (AUTHOR), Campo, Brice2 (AUTHOR) campob@mmv.org, Alexander, Stephen P. H.3 (AUTHOR), Arendse, Lauren B.4 (AUTHOR), Cheng, Xiu5 (AUTHOR), Davenport, Anthony P.6 (AUTHOR), Faccenda, Elena1 (AUTHOR), Fidock, David A.7,8 (AUTHOR), Godinez‐Macias, Karla P.9 (AUTHOR), Harding, Simon D.1 (AUTHOR), Kato, Nobutaka5 (AUTHOR), Lee, Marcus C. S.10 (AUTHOR), Luth, Madeline R.11 (AUTHOR), Mazitschek, Ralph12 (AUTHOR), Mittal, Nimisha13 (AUTHOR), Niles, Jacquin C.14 (AUTHOR), Okombo, John7 (AUTHOR), Ottilie, Sabine11 (AUTHOR), Pasaje, Charisse Flerida A.14 (AUTHOR), Probst, Alexandra S.15 (AUTHOR)
Publikováno v:
British Journal of Pharmacology. Aug2023, Vol. 180 Issue 15, p1899-1929. 31p. 1 Diagram, 3 Charts.
Autor:
Arendse, Lauren B., Murithi, James M., Qahash, Tarrick, Pasaje, Charisse Flerida A., Godoy, Luiz C., Dey, Sumanta, Gibhard, Liezl, Ghidelli-Disse, Sonja, Drewes, Gerard, Bantscheff, Marcus, Lafuente-Monasterio, Maria J., Fienberg, Stephen, Wambua, Lynn, Gachuhi, Samuel, Coertzen, Dina, van der Watt, Mariëtte, Reader, Janette, Aswat, Ayesha S., Erlank, Erica, Venter, Nelius
Publikováno v:
Science Translational Medicine; 10/19/2022, Vol. 14 Issue 667, p1-15, 15p
Publikováno v:
Annual Review of Microbiology; Sep2022, Vol. 76, p67-90, 19p
Autor:
Kalita T; Department of Pharmaceutical Sciences, Girijananda Chowdhury Institute of Pharmaceutical Science, Hatkhowapara, Azara, Guwahati, Assam, India., Choudhury A; Department of Pharmacy, Silchar Medical College and Hospital, Silchar, Assam, India., Shakya A; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, 786004, India., Ghosh SK; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, 786004, India., Singh UP; Drug Design & Discovery Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh, 211007, India., Bhat HR; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, 786004, India.
Publikováno v:
Current drug discovery technologies [Curr Drug Discov Technol] 2024; Vol. 21 (5), pp. e240124226141.
Characterization of Competitive Inhibitors of Plasmodium falciparum cGMP‐Dependent Protein Kinase**.
Autor:
Eck, Tyler, Laureano de Souza, Mariana, Delvillar, Melvin, Ashraf, Kutub, Yadav Bheemanaboina, Rammohan R., Chakrasali, Ramappa, Kreiss, Tamara, Siekierka, John J., Rotella, David P., Bhanot, Purnima, Goodey, Nina M.
Publikováno v:
ChemBioChem; 4/5/2022, Vol. 23 Issue 7, p1-8, 8p
Autor:
Castillo-Aguilera, Omar, Depreux, Patrick, Ballée, Alexia, Beaurain, Florian, Arimondo, Paola B., Goossens, Laurence
Publikováno v:
Synlett; 2020, Vol. 31 Issue 12, p1216-1220, 5p
Autor:
Yu, Bingting1 (AUTHOR), Mamedov, Ruslan1 (AUTHOR), Fuhler, Gwenny M.1 (AUTHOR) b.yu@erasmusmc.nl, Peppelenbosch, Maikel P.1 (AUTHOR) m.peppelenbosch@erasmusmc.nl, Abián, Olga (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Mar2021, Vol. 22 Issue 5, p2623-2623. 1p.
Autor:
Ressurreição M; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Moon RW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., van Ooij C; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. christiaan.vanooij@lshtm.ac.uk.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2470, pp. 101-120.